West Pharmaceutical Services | WST - Zinsaufwendungen Für Schuld





Zinsaufwendungen Für Schuld Veränderung Datum
Align Technology USD 6.93M 9.11M 2026-03
Baxter International USD 78M 20M 2026-03
Becton, Dickinson and Co. USD 132M 17M 2026-06
Cerus USD 2.33M 96K 2024-06
Charles River Laboratories USD 30.34M 3.6M 2026-06
Cooper Companies USD 20.9M 1.5M 2026-03
Dentsply International USD 22M 2M 2026-06
Haemonetics USD 5.08M 2.32M 2026-03
ICU Medical USD 18.53M 2.11M 2026-03
Insulet USD 11M 3.7M 2026-06
Integra LifeSciences USD 22.99M 529K 2026-06
IQVIA Holdings USD 197M 5M 2026-06
J&J USD 43M 25M 2026-03
Medtronic USD 176M 5M 2026-03
Merit Medical Systems USD 12.12M 5.59M 2026-06
Neogen USD 13.9M 356K 2025-12
OraSure Technologies 1.67M 1.13M 2025-12
Quidel USD 5.63B 5.58B 2026-03
Repligen USD 5.66M 85K 2026-06
Rockwell Medical USD 232K 199K 2024-06
Solventum Corp USD 14.24B 146M 2026-06
STAAR Surgical USD 800K 799K 2025-09
Terumo JPY 1.48B 51M 2026-06
West Pharmaceutical Services USD 1.9M 1.7M 2026-03